Scrophularia nodosa (Figwort)

Scrophularia nodosa (figwort) is a European herb containing iridoid glycosides like harpagoside that traditionally supports lymphatic drainage and inflammatory conditions. The bioactive compounds work through modulation of inflammatory pathways and lymphatic circulation enhancement.

Origin & History

Scrophularia nodosa (figwort) is a perennial herb native to temperate regions of the Northern Hemisphere, belonging to the Scrophulariaceae family. The aerial parts (stems, leaves, and flowering tops) are harvested and prepared as infusions, tinctures, dried herb, or extracts. The plant contains iridoid glycosides (aucubin, harpagide, harpagoside), flavonoids, phenolic acids, and amino acids.

Historical & Cultural Context

In Western herbalism and North American eclectic medicine, figwort has been used for centuries as a lymphatic alterative for scrofula (tubercular lymph node swelling), chronic skin diseases, and glandular obstructions. Historical texts describe it as promoting waste excretion and resolving cacoplastic deposits, typically used as infusions, syrups, or topical preparations.

Health Benefits

• Anti-inflammatory support through iridoid glycosides like harpagoside (Traditional evidence only)
• Lymphatic system support for glandular health and waste elimination (Traditional use evidence)
• Potential antimalarial activity based on related species showing activity against Plasmodium falciparum (In vitro evidence only)
• Skin health support for chronic conditions (Traditional use evidence)
• Antioxidant effects from flavonoids and phenolic compounds (Preliminary evidence)

How It Works

Scrophularia nodosa contains iridoid glycosides, particularly harpagoside, which modulate inflammatory pathways by inhibiting pro-inflammatory cytokine production. The herb's compounds support lymphatic circulation by enhancing tissue drainage and promoting glandular health. Traditional mechanisms suggest interaction with lymphatic vessel tone and cellular waste elimination processes.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Scrophularia nodosa were identified. Evidence is limited to traditional use and in vitro studies on related Scrophularia species showing antimalarial activity attributed to cardiac glycosides and flavonoids. PubMed review PMC6130519 details phytochemicals across the genus but lacks clinical trial data for S. nodosa.

Clinical Summary

Clinical evidence for Scrophularia nodosa remains limited, with most support coming from traditional European herbalism practices. Related species have shown antimalarial activity against Plasmodium falciparum in laboratory studies, but human clinical trials are lacking. The anti-inflammatory and lymphatic benefits are based primarily on traditional use patterns and preliminary phytochemical analysis. More rigorous clinical research is needed to establish therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

Scrophularia nodosa is a medicinal herb with limited nutritional value as a food source; its profile is dominated by bioactive phytochemicals rather than macronutrients. Macronutrient content is negligible in typical medicinal preparations. Key bioactive compounds include: iridoid glycosides (harpagoside and aucubin, estimated 0.1–1.5% dry weight of aerial parts and roots), which are the primary pharmacologically active constituents; flavonoids including diosmin, acacetin, and luteolin (collectively estimated 0.5–2% dry weight); phenylpropanoid glycosides including acteoside (verbascoside, approximately 0.3–1.0% dry weight); saponins present in trace to moderate concentrations (specific quantification limited in literature); phenolic acids including caffeic acid and ferulic acid derivatives (estimated 0.2–0.8% dry weight); alkaloids present in very low concentrations (specific types and quantities poorly characterized); small quantities of cardioactive glycosides have been historically noted, warranting caution. Mineral content includes modest potassium, calcium, and magnesium typical of herbaceous plants, but no significant micronutrient contributions at typical medicinal doses. Bioavailability notes: iridoid glycosides are generally water-soluble and extractable via aqueous infusions; harpagoside bioavailability is enhanced in alcoholic tinctures compared to water-only preparations; flavonoids exhibit moderate gut absorption with significant inter-individual variation due to microbiome-dependent metabolism. Most quantitative phytochemical data is extrapolated from related Scrophulariaceae species due to limited species-specific analytical studies.

Preparation & Dosage

Traditional dosing includes: infusion (1 tablespoon herb infused 15 minutes, 3x daily), tincture (2-4 mL 3x daily at 1:5 in 45% alcohol, max 20 mL weekly), dried herb (2-8 g 3x daily), or capsules (250 mg, 2 capsules 3x daily). No clinically studied dosages available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Devil's Claw, Cleavers, Red Clover, Echinacea, Burdock Root

Safety & Interactions

Scrophularia nodosa is generally considered safe when used traditionally, but comprehensive safety data is limited. Potential interactions with blood-thinning medications may occur due to the herb's circulatory effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use given the herb's immune-modulating properties.